Los puntos clave no están disponibles para este artículo en este momento.
A thorough understanding of the broad spectrum of clinical manifestations of PD is essential to the proper diagnosis of the disease. Genetic mutations or variants, neuroimaging abnormalities and other tests are potential biomarkers that may improve diagnosis and allow the identification of persons at risk.
Joseph Jankovic (Fri,) studied this question.